Table-6.
Compounds | Absorption | Distribution | Metabolism | Carcinogenic | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||||
HIA (%) | Caco-2 | Plasma protein binding (%) | blood brain barrier | 3A4 substrate | 2D6 substrate | 1A2 inhibitor | C19 inhibitor | 2C9 inhibitor | 2D6 inhibitor | 3A4 inhibitor | ||
| ||||||||||||
Log (10−6cm/s) | ||||||||||||
Gallic aci | 43.37 | −0.081 | 38.3 | −1.855 | No | No | No | No | No | No | No | - |
Pyrogallol | 83.55 | 1.12 | 28.8 | −0.441 | No | No | No | No | No | No | No | - |
Caffeic acid | 69.41 | 0.634 | 38,7 | −0.647 | No | No | No | No | No | No | No | + |
Vanillic acid | 78.15 | 0.33 | 50.2 | −0.38 | No | No | No | No | No | No | No | - |
Syringic acid | 73.07 | 0.495 | 39.1 | −0.191 | No | No | No | No | No | No | No | - |
Rutin | 23.45 | −0.949 | 81.3 | −1.898 | No | No | No | No | No | No | No | - |
Naringenin | 91.31 | 1.029 | 93.6 | −0.578 | No | No | Yes | No | No | No | No | - |
Limonene | 95.89 | 1.401 | 61.4 | 0.732 | No | No | No | No | No | No | No | - |
cis-β-ocimene | 94.73 | 1.406 | 23.9 | −1.848 | No | No | No | No | No | No | No | - |
Allo-ocimene | 95.45 | 1.419 | 25.4 | 0.746 | No | No | No | No | No | No | No | + |
Linalool oxide | 93.91 | 1.584 | 46 | 0.368 | No | No | No | No | No | No | No | - |
Linalool | 93.16 | 1.493 | 51.6 | 0.598 | No | No | No | No | No | No | No | - |
Methyl salicylate | 89.46 | 1.202 | 51 | −0.222 | No | No | No | No | No | No | No | - |
Eucalyptol | 96.51 | 1.485 | 44.7 | 0.368 | No | No | No | No | No | No | No | - |
Palmitic acid | 92 | 1.558 | 89.9 | −0.111 | No | Yes | No | No | No | No | No | - |
Oleic acid | 91.82 | 1.563 | 94.8 | −0.168 | Yes | Yes | No | No | No | No | No | - |
Linoleic acid | 92.33 | 1.57 | 94.6 | −0.142 | Yes | Yes | No | No | No | No | No | - |
Praziquantel | 93.42 | 1.759 | 55.2 | 0.468 | No | Yes | No | Yes | No | No | No | - |